Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Epidemiology

Medicine

Immunology

Microbiology

Show all topics

DOI

10.1101/2022.05.24.493348

License

CC-BY-NC

Other Formats

PDF